Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Complete Title: An Open-label, Multicenter, Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Efficacy of BA3182, a Bispecific Epithelial Cell Adhesion Molecule (EpCAM)/CD3 Antibody, in Patients with Advanced Adenocarcinoma
Trial Phase: I
Investigator: Gabriela Chiorean
The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma
Keywords:
- Adenocarcinoma
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.